Tactile Systems Tech Files 8-K on Director Changes
Ticker: TCMD · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1027838
| Field | Detail |
|---|---|
| Company | Tactile Systems Technology Inc (TCMD) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $145,000, $145,000 b, $50,000, $10,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-of-directors
Related Tickers: TCMD
TL;DR
Tactile Systems Tech (TCMD) filed an 8-K on Jan 10th about board and exec comp changes.
AI Summary
On January 10, 2025, Tactile Systems Technology, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing includes the election of new directors and potentially updates to the compensatory arrangements for certain officers, though specific details on dollar amounts or new appointments are not elaborated in this summary section.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence and stock performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance matters such as director elections and compensation arrangements, which typically carry low immediate risk.
Key Players & Entities
- TACTILE SYSTEMS TECHNOLOGY, INC. (company) — Registrant
- January 10, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Minneapolis, MN (location) — Principal business address
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors and departure of directors, but the specific names and details of these changes are not provided in the summary information.
Were there any new executive appointments mentioned in the filing?
The filing notes 'Appointment of Certain Officers' as an item, but does not specify any new appointments or the individuals involved.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported is dated January 10, 2025.
What is the primary business of Tactile Systems Technology, Inc. according to the filing?
The filing lists the Standard Industrial Classification as 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.
Where is Tactile Systems Technology, Inc. headquartered?
The principal business address is listed as 3701 Wayzata Blvd, Suite 300, Minneapolis, MN 55416.
Filing Stats: 1,045 words · 4 min read · ~3 pages · Grade level 11.1 · Accepted 2025-01-13 08:20:33
Key Financial Figures
- $0.001 — registered Common Stock, Par Value $0.001 Per Share TCMD The Nasdaq Stock Marke
- $145,000 — ) with a value of a pro rata portion of $145,000, such pro rata portion based on the num
- $145,000 b — ted by dividing the pro rata portion of $145,000 by the closing sale price per share of th
- $50,000 — will receive an annual cash retainer of $50,000 per year for her service on the board,
- $10,000 — ervice on the board, a cash retainer of $10,000 per year for her service as a member of
- $5,000 — Audit Committee, and a cash retainer of $5,000 per year for her service as a member of
Filing Documents
- tm253038d1_8k.htm (8-K) — 30KB
- tm253038d1_ex99-1.htm (EX-99.1) — 5KB
- tm253038d1_ex99-1img01.jpg (GRAPHIC) — 4KB
- 0001104659-25-002876.txt ( ) — 214KB
- tcmd-20250110.xsd (EX-101.SCH) — 3KB
- tcmd-20250110_lab.xml (EX-101.LAB) — 33KB
- tcmd-20250110_pre.xml (EX-101.PRE) — 22KB
- tm253038d1_8k_htm.xml (XML) — 4KB
02
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On January 10, 2025, the board of directors of Tactile Systems Technology, Inc. (the "Company") elected Laura G. King to serve as a member of the board and fixed the size of the board at nine directors, all effective as of January 13, 2025 . Ms. King was also appointed to serve as a member of the Audit Committee and of the Compliance and Reimbursement Committee of the board. Ms. King is a seasoned healthcare executive with a proven track record of leadership and developing innovative products that enhance patient care. Her extensive experience includes a 22-year career at General Electric Company (GE), where she served as a Company Officer in her role as President and Chief Executive Officer of GE Healthcare's Global Interventional Business, which provided clinical solutions enabling minimally invasive procedures in cardiology, interventional radiology, and surgery. Her earlier experience at GE included various senior level audit and finance roles, including Chief Information Officer and Chief Financial Officer, Consumer and ECM Motors. Ms. King is currently co-founder and Chief Executive Officer of BiaCure, Inc., a developer of effective treatments for nail fungus. Previously, she co-founded and served as Chief Executive Officer of Elucent Medical, a developer of a real-time surgical navigation platform that has positively impacted over 10,000 breast cancer patients. Ms. King also served as President and Chief Executive Officer of NeuWave Medical, a manufacturer and marketer of a minimally invasive soft tissue microwave ablation system to destroy tumor cells, which was acquired by Johnson & Johnson's MedTech division. For her service on the board, Ms. King will be compensated in accordance with the Company's non-employee director compensation policy. Ms. King will be granted restricted stock units ("RSUs")
01
Item 7.01. Regulation FD Disclosure On January 13, 2025, the Company issued a press release in connection with Ms. King's appointment to the board. Attached hereto as Exhibit 99.1 is a copy of the press release. In accordance with General Instruction B.2 of Form 8-K, the information in this report under this heading, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 99.1 Press Release dated January 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TACTILE SYSTEMS TECHNOLOGY, INC. Date: January 13, 2025 By: /s/ Elaine M. Birkemeyer Elaine M. Birkemeyer Chief Financial Officer